Page 330 - Binder
P. 330

Nomination Recognition 2017


        Report by Cross Functional Team

       CATEGORY:         CROSS FUNCTIONAL TEAM AWARD

       PROJECT:          FDA Quality Metrics Submission Readiness

       CATEGORY:        INNOVATIVE WAYS OF WORKING

       NOMINATOR:       Gregory Sliwinski
       SPONSOR:         4764

       LEADER:

       PROFILE:
       Describe the situation or event related to the individual's or team's performance.
       The team demonstrated effective whole systems thinking while developing an
       approach that would result in an accurate and FDA defensible outcome.  The team
       was able to demonstrated new ways of working by examining how data is captured
       in SAP and then mapped it across different systems, including customer complaints
       and lab results and Quality Notifications.

       Describe in detail the individual's or team's notable behaviors.

        Team was focused on ensuring a high degree of accuracy in the face of paving new
        territory for FDA while looking for insights that can be used for future continuous
        improvement activities.  One particular area was the rate of "invalidated lab OOS
        results" for certain active ingredients.  In some cases the lab OOS results are
        invalidated 100% of the time; this would potentially be a big red flag during an FDA
        inspection and could, possibly, result in market action being required.  Through the
        work of this team, high rates of invalidated lab OOS results will be examined to
        determine root cause (such as questionable test methods) to ensure that GOJO
        does not face FDA scrutiny in the future.


       What were the results of the individual’s or team’s behaviors?
        The team was able to sort through and effectively interpret the FDA Quality Metrics
        guidance documents which have evolved over the past couple of years.  Through
        the team's efforts, GOJO is ready to submit the required data FDA is looking for in
        the proper format the FDA requires.  Due to the complex nature of our SKU's and
        formats, there was an extensive amount of data scrubbing required to ensure that
        our submittal accurately reflects GOJO's quality metrics in terms of unit doses
        shipped, complaint rates and Out-of-specification (OOS) performance.



       NOMINEE                           DEPARTMENT

       Dennis Fuster (5542)              Quality Assurance 204100
       Richard King (8748)               Quality Assurance 204100

       Nathan Schaus (4506)              Quality Assurance 204100
       Frederick Wallace (7257)          Quality Assurance 204100






      rptCrossFunctionalTeamNominations                                           Tuesday, February 13, 2018  330
   325   326   327   328   329   330   331   332   333   334   335